TriPath Shareholders Okay Acquisition

Shareholders of Burlington, NC-based TriPath Imaging approved the buyout of its remaining stock by Franklin Lakes, NJ-based Becton Dickinson for $9.25 per share.

In September, Becton Dickinson, a manufacturer of syringes and other medical devices, agreed to buy the remaining 93.5% of TriPath stock it did not already own.

The deal is expected to close on or about Dec. 20. TriPath is a manufacturer of cancer diagnostic tools.